Sarah Boseley comments at the Guardian: Tahir Amin says Abbott had it coming, accusing the company of holding its HIV drug prices at an unaffordable level for the developing world for years. Amin hopes this is not just a single victory, but a game-changer. He hopes other big pharma companies will take heed and tell their lawyers not to seek new ways to gain or renew patents on drugs that are badly needed in poor countries.
Learn more about how you can help build a more equitable system for all Notice: JavaScript is required for this content.